Importance of animal models in schizophrenia research

被引:63
|
作者
van den Buuse, M [1 ]
Garner, B [1 ]
Gogos, A [1 ]
Kusljic, S [1 ]
机构
[1] Mental Hlth Res Inst Victoria, Behav Neurosci Lab, Parkville, Vic 3052, Australia
来源
关键词
amphetamine; animal models; genetically modified animals; motor activity; prepulse inhibition; schizophrenia;
D O I
10.1111/j.1440-1614.2005.01626.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective:This review aims to summarize the importance of animal models for research on psychiatric illnesses, particularly schizophrenia. Method and Results: Several aspects of animal models are addressed, including animal experimentation ethics and theoretical considerations of different aspects of validity of animal models. A more specific discussion is included on two of the most widely used behavioural models, psychotropic drug-induced locomotor hyperactivity and prepulse inhibition, followed by comments on the difficulty of modelling negative symptoms of schizophrenia. Furthermore, we emphasize the impact of new developments in molecular biology and the generation of genetically modified mice, which have generated the concept of behavioural phenotyping. Conclusions: Complex psychiatric illnesses, such as schizophrenia, cannot be exactly reproduced in species such as rats and mice. Nevertheless, by providing new information on the role of neurotransmitter systems and genes in behavioural function, animal 'models' can be an important tool in unravelling mechanisms involved in the symptoms and development of such illnesses, alongside approaches such as post-mortem studies, cognitive and psychophysiological studies, imaging and epidemiology.
引用
收藏
页码:550 / 557
页数:8
相关论文
共 50 条
  • [31] Effects of(-)stepholidine in animal models for schizophrenia
    Bart A ELLENBROEK
    ActaPharmacologicaSinica, 2006, (09) : 1111 - 1118
  • [32] Effects of (-)stepholidine in animal models for schizophrenia
    Ellenbroek, Bart A.
    Zhang, Xue-xiang
    Jin, Guo-zhang
    ACTA PHARMACOLOGICA SINICA, 2006, 27 (09) : 1111 - 1118
  • [33] NEURODEVELOPMENTAL ANIMAL-MODELS OF SCHIZOPHRENIA
    LILLRANK, SM
    LIPSKA, BK
    WEINBERGER, DR
    CLINICAL NEUROSCIENCE, 1995, 3 (02) : 98 - 104
  • [34] An Overview of Animal Models Related to Schizophrenia
    Winship, Ian R.
    Dursun, Serdar M.
    Baker, Glen B.
    Balista, Priscila A.
    Kandratavicius, Ludmyla
    Maia-de-Oliveira, Joao Paulo
    Hallak, Jaime
    Howland, John G.
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2019, 64 (01): : 5 - 17
  • [35] Genetic animal models: focus on schizophrenia
    Gainetdinov, RR
    Mohn, AR
    Caron, MG
    TRENDS IN NEUROSCIENCES, 2001, 24 (09) : 527 - 533
  • [36] Promise and Pitfalls of Animal Models of Schizophrenia
    David Feifel
    Paul D. Shilling
    Current Psychiatry Reports, 2010, 12 : 327 - 334
  • [37] NMDAR Hypofunction Animal Models of Schizophrenia
    Lee, Gloria
    Zhou, Yi
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2019, 12
  • [38] Advantages and Limitations of Animal Schizophrenia Models
    Bialon, Magdalena
    Wasik, Agnieszka
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (11)
  • [39] Animal models of schizophrenia: a critical review
    Marcotte, ER
    Pearson, DM
    Srivastava, LK
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2001, 26 (05): : 395 - 410
  • [40] Animal models for the negative symptoms of schizophrenia
    Ellenbroek, BA
    Cools, AR
    BEHAVIOURAL PHARMACOLOGY, 2000, 11 (3-4): : 223 - 233